Stephen Whitehead, chief executive of Association of the British Pharmaceutical Industry, defends the ethics of the industry following GSK's guilty plea for drug violations.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
沒有留言:
張貼留言